Learn about the field’s first genetic circuits and read forecasts by George M. Church and J. Craig Venter of a future where man-made organisms pump out novel fuels, drugs, and therapies.
-
- The Scientist »
- Magazine »
- Features »
Features
Most Recent
What does a normally aging brain look like? Are diseases of aging such as Alzheimer’s inevitable?
Researchers and pharma companies have tried to attack this disease by reducing amyloid plaques, but inflammation may be the real culprit.
For more than 100 years, pathologists have observed cancer cells engulfing other live cells, but scientists are only now beginning to understand how it happens and what it means for tumorigenesis.
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
An account of the path to realizing tools for controlling brain circuits with light
A new breed of vaccines aims to wean users off cocaine.
Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
Subjects
- cancer
- cell & molecular biology
- clinical trials
- disease/medicine
- drug development
- funding
- genetics & genomics
- immunology
- microbiology
- neuroscience
Sub Categories
- Bio Business
- Capsule Reviews
- Careers
- Contributors
- Critic At Large
- Editorial
- Features
- Foundations
- Lab Tools
- Modus Operandi
- Notebook
- Profile
- Reading Frames
- Scientist to Watch
- Speaking of Science
- The Literature
- Thought Experiment
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
